61424-81-5 Usage
Uses
Given the provided materials do not specify the uses of 2-AMINO-5-OXO-5H-(1) BENZOPYRANO-(2,3-B)-PYRIDINE-3-CARBONITRILE, it is not possible to list its applications based on the information at hand. However, based on its classification as an organic compound with a pyridine ring and carbonitrile group, potential uses could include:
Used in Organic Synthesis:
2-AMINO-5-OXO-5H-(1) BENZOPYRANO-(2,3-B)-PYRIDINE-3-CARBONITRILE could be used as an intermediate or building block in the synthesis of more complex organic molecules for various applications, such as pharmaceuticals or agrochemicals, due to its unique structural features.
Used in Medicinal Chemistry:
It may serve as a lead compound or a structural component in the development of new drugs, given its potential to interact with biological targets, although its specific pharmacological properties would need to be determined through further research.
Used in Materials Science:
2-AMINO-5-OXO-5H-(1) BENZOPYRANO-(2,3-B)-PYRIDINE-3-CARBONITRILE might also find use in the development of new materials, such as sensors or advanced polymers, owing to its chemical structure, which could confer specific properties to materials in which it is incorporated.
Check Digit Verification of cas no
The CAS Registry Mumber 61424-81-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,4,2 and 4 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 61424-81:
(7*6)+(6*1)+(5*4)+(4*2)+(3*4)+(2*8)+(1*1)=105
105 % 10 = 5
So 61424-81-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H7N3O2/c14-6-7-5-9-11(17)8-3-1-2-4-10(8)18-13(9)16-12(7)15/h1-5H,(H2,15,16)
61424-81-5Relevant academic research and scientific papers
Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
-
, (2008/06/13)
Aminocyanopyridine compounds are described which are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2. Pharmaceutical compositions and kits are also described, which include an anminocyanopyridine MK-2 inhibiting compound.
